title: In Reply: Safety and Efficacy Issues of Tirofiban Use in Endovascular Procedures: What Are the Actual Indications?
authors.affiliation: *Department of Neurosurgery, Thomas Jefferson University and Jefferson Hospital for Neuroscience, Philadelphia, Pennsylvania ‡Department of Neurosurgery, Carver College of Medicine, University of Iowa, Iowa City, Iowa.
authors.forename: Nohra
authors.initials: N
authors.lastname: Chalouhi
authors.forename: Badih
authors.initials: B
authors.lastname: Daou
authors.forename: Pascal
authors.initials: P
authors.lastname: Jabbour
authors.forename: Robert M
authors.initials: RM
authors.lastname: Starke
authors.forename: David M
authors.initials: DM
authors.lastname: Hasan
mesh_terms: D057510:Endovascular Procedures; D006801:Humans; D009203:Myocardial Infarction; D010975:Platelet Aggregation Inhibitors; D000077466:Tirofiban; D016896:Treatment Outcome; D014443:Tyrosine / Q000031:analogs & derivatives
chemical_list: D010975:Platelet Aggregation Inhibitors; D014443:Tyrosine; D000077466:Tirofiban